Lotte Biologics Launches 255 Billion Won Rights Issue for Songdo Plant
4h ago
Source
Seoul Economic DailyLotte Biologics Launches 255 Billion Won Rights Issue for Songdo Plantsedaily.comLotte Biologics is launching a 255.3 billion won rights issue to build Plant No. 1 at its Songdo Bio Campus, bringing Lotte Group's total bio investment close to 1 trillion won.
You might also wanna read
Merck KGaA acquires Bio-Techne in $11 billion all-cash deal to bolster life sciences division
Merck KGaA has agreed to acquire Bio-Techne for approximately $11 billion in an all-cash deal, aiming to strengthen its life sciences portfo

Terra Bioindustries Secures $1.1M to Convert Brewery Waste into Food Ingredients
Toronto-based Terra Bioindustries, in partnership with Great Western Brewing Company (Saskatoon), has secured $1.1 million in funding (inclu
vegan-news.net·1mo agoGreater Bay Area emerges as launchpad for China's biotech rise
shanghaisun.com·2d ago
Protuoso Biosciences raises $9.5M for AI-designed multifunctional biologic drugs
Protuoso Biosciences, a California-based startup, has raised $9.5 million to advance its AI-designed multifunctional biologics platform. The
longevity.technology·1mo agoChina's biotech rise: A case study in multiple myeloma drug development
This article examines China's rapid advancement in biotechnology through the lens of a multiple myeloma drug development case study. It disc

Cancer therapy spinout Myricx Bio agrees to US$1.5B acquisition by Novartis
Myricx Bio, a cancer therapy spinout from the Francis Crick Institute and Imperial College London, has agreed to be acquired by Novartis in

Comments
Sign in to join the conversation.
No comments yet. Be the first.